TY  - JOUR

T1  - Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

JO  - Diabetes Care

UR  - https://eprints.whiterose.ac.uk/id/eprint/107739

UR  - https://doi.org/10.2337/dc12-1333

PY  - 2013/05/01

AU  - Davies M

AU  - Heller S

AU  - Sreenan S

AU  - Sapin H

AU  - Adetunji O

AU  - Tahbaz A

AU  - Vora J

ED  - 

DO  - DOI: 10.2337/dc12-1333

PB  - American Diabetes Association

VL  - 36

IS  - 5

SP  - 1368

EP  - 1376

Y2  - 2025/11/01

ER  -